title: The BCR/ABL-extra signal fluorescence in situ hybridization system reliably detects deletions upstream of the ABL locus: implications for reporting of results and followup of chronic myelogenous leukemia patients.
authors.forename: Christel
authors.initials: C
authors.lastname: Müller
authors.forename: Evelin
authors.initials: E
authors.lastname: Hennig
authors.forename: Christina
authors.initials: C
authors.lastname: Franke
authors.forename: Rainer
authors.initials: R
authors.lastname: Krahl
authors.forename: Sabine
authors.initials: S
authors.lastname: Leiblein
authors.forename: Dietger
authors.initials: D
authors.lastname: Niederwieser
authors.forename: Michael W N
authors.initials: MW
authors.lastname: Deininger
mesh_terms: D002872:Chromosome Deletion; D002892:Chromosomes, Human, Pair 22; D002899:Chromosomes, Human, Pair 9; D005500:Follow-Up Studies; D016044:Fusion Proteins, bcr-abl; D006801:Humans; D017404:In Situ Hybridization, Fluorescence / Q000379:methods*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics*
chemical_list: D016044:Fusion Proteins, bcr-abl